The Veterinary Molecular Diagnostics Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size for veterinary molecular diagnostics has seen quick expansion in recent years. It was valued at $0.63 billion in 2024 and is expected to rise to $0.7 billion in 2025, experiencing a compound annual growth rate (CAGR) of 10.1%.
The Veterinary Molecular Diagnostics market is projected to reach a size of $1.01 billion by 2029, growing at a compound annual growth rate (CAGR) of 9.7%.
Download Your Free Sample of the 2025 Veterinary Molecular Diagnostics Market Report and Uncover Key Trends Now!The key drivers in the veterinary molecular diagnostics market are:
• Rising adoption of companion animals
• Increasing adoption rates of pet insurance
• Surge in pet population
• Increasing animal healthcare expenditure
• Increasing demand for animal diagnostic tests
• Technological advancements in veterinary molecular diagnostic technologies
• Emergence of advanced laboratory devices
• Advancements in technologies such as PCR, NGS, and microarray.
The veterinary molecular diagnostics market covered in this report is segmented –
1) By Product: Kits And Reagents, Instrument
2) By Animal Type: Companion Animals, Livestock Animals
3) By Application: Infectious Diseases, Genetic Diseases, Other Applications
4) By End-User: Diagnostic Laboratories, Veterinary Clinics, Veterinary Hospitals, Other End-Users
Subsegments:
1) Kits and Reagents: Polymerase Chain Reaction (PCR) Kits, Reverse Transcription PCR (RT-PCR) Kits, Real-Time PCR Kits, Nucleic Acid Extraction Kits, Enzyme-linked Immunosorbent Assay (ELISA) Kits, Hybridization Kits, Reagents for Next-Generation Sequencing (NGS)
2) Instruments: PCR Machines (Thermal Cyclers), Real-Time PCR Machines, Nucleic Acid Analyzers, Gel Electrophoresis Equipment, DNA Sequencers, Automated Liquid Handling Systems, Molecular Imaging Systems
The key trends in the veterinary molecular diagnostics market are:
• Technological progress in veterinary molecular diagnostic techniques is a key emerging trend.
• The development of advanced laboratory devices is becoming increasingly crucial.
• Improvements in techniques such as PCR, next-generation sequencing (NGS), and microarray technology are on the rise.
• There is an increasing demand for animal diagnostic tests because of the rise in companion animal adoption and pet insurance.
Major players in the veterinary molecular diagnostics market are:
• Roche Diagnostics Corporation
• Thermo Fisher Scientific Inc.
• Merck KGaA
• Zoetis Inc.
• Illumina Inc.
• PerkinElmer Inc.
• bioMérieux S.A.
• IDEXX Laboratories Inc.
• Bio-Rad Laboratories Inc.
• QIAGEN N.V.
• LGC Group Ltd.
• Neogen Corporation
• Abcam plc
• Eiken Chemical Co. Ltd.
• Bioneer Corporation
• INDICAL BIOSCIENCE GmbH
• Biochek B.V.
• Ring Biotechnology Co. Ltd.
• Ingenetix GmbH
• MiDOG Animal Diagnostics LLC
• Biolab S.r.l.
• Bionote USA Inc.
North America was the largest region in the Veterinary Molecular Diagnostics market in 2024